CBD Life Sciences Inc. (OTCMKTS:CBDL – Get Free Report) was the recipient of a large increase in short interest during the month of July. As of July 15th, there was short interest totaling 1,019,814 shares, an increase of 919.8% from the June 30th total of 100,000 shares. Based on an average trading volume of 37,832,732 shares, the days-to-cover ratio is presently 0.0 days.
CBD Life Sciences Price Performance
Shares of CBDL opened at $0.00 on Friday. CBD Life Sciences has a 12-month low of $0.00 and a 12-month high of $0.00.
About CBD Life Sciences
CBD Life Sciences, Inc is a U.S.-based company focused on developing and commercializing cannabinoid‐enhanced products for the wellness and consumer healthcare markets. The company’s core strategy centers on leveraging plant-derived phytocannabinoids, along with complementary natural ingredients, to formulate a range of topical and ingestible offerings. CBD Life Sciences operates under an emerging‐brand model, seeking to position its products at the intersection of pharmaceutical‐grade quality and mainstream consumer appeal.
The company’s product portfolio includes broad‐spectrum hemp-derived topical creams, gels and balms designed for localized relief, as well as oral formulations such as capsules, tinctures and soft gels aimed at general wellness support.
Featured Stories
- Five stocks we like better than CBD Life Sciences
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
